Construction of the Patient-Oriented Prostate Utility Scale (PORPUS): A multiattribute health state classification system for prostate cancer

Journal of Clinical Epidemiology

Volumn 53, Issue 9, 2000, Pages 920-930

  Krahn, Murray ^a,b   Ritvo, Paul ^a,b,c,d   Irvine, Jane ^a,b   Tomlinson, George ^b   Bezjak, Andrea ^a,b   Trachtenberg, John ^a   Naglie, Gary ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Division of Epidemiology   (Canada)

^d CANCER CARE ONTARIO   (Canada)

Author keywords

Decision support techniques; Prostate neoplasms; Quality adjusted life years; Quality of life; Social values

Indexed keywords

ARTICLE; DISEASE SEVERITY; HEALTH STATUS; HUMAN; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOMETRY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SCORING SYSTEM; SOCIAL PSYCHOLOGY;

HEALTH STATUS INDICATORS; HUMAN; MALE; ONTARIO; PROSTATIC NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0033825904     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00211-0     Document Type: Article

References (63)

1. Williams A. The measurement and valuation of health: a chronicle. Discussion paper 136. York, Great Britain: Centre for Health Economics, University of York, 1995.
2. Elvik R. The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med. 40:1996;1385-1398.
3. Sculpher M.J., Dwyer N., Byford S., Stirrat G.M. Randomised trial comparing hysterectomy and transcervical endometrial resection. effect on health related quality of life and costs two years after surgery Br J Obstet Gynaecol. 103:1996;142-149.
4. Hollingworth W., Mackenzie R., Todd C.J., Dixon A.K. Measuring changes in quality of life following magnetic resonance imaging of the knee. SF-36, EuroQol, or Rosser Index Qual Life Res. 4:1995;325-334.
5. Barr R.D., Furlong W., Dawson S. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol. 15:1993;284-290.
6. Saigal S., Rosenbaum P., Stoskopf B. Comprehensive assessment of the health status of extremely low birthweight children at eight years of age. comparison with a reference group J Pediatr. 125:1994;411-417.
7. Statistics Canada Health Status of Canadians. Report of the 1991 General Social Survey:1994;Statistics Canada, Ottawa.
8. Patrick D.L., Bush J.W., Chen M.M. Toward an operational definition of health. J Health Soc Behav. 14:1973;6-23.
9. Kaplan R.M., Anderson J.P. A general health policy model. update and applications Health Services Res. 23:1988;203-235.
10. Kaplan R.M., Feeny D., Revicki D.A. Methods for assessing relative importance in preference based outcome measures. Qual Life Res. 2:1993;467-475.
11. Dolan P. Modeling valuations for EuroQol Health States. Med Care. 35:1997;1095-1108.
12. Feeny D., Furlong W., Boyle M., Torrance G.W. Multi-attribute health status classification systems. Health Utilities Index Pharamacoeconomics. 7:1995;490-502.
13. Torrance G.W., Furlong W., Feeny D., Boyle M. Multi-attribute preference functions. Health Utilities Index Pharmacoeconomics. 7:1995;503-520.
14. Torrance G.W. Utility approach to measuring health-related quality of life. J Chron Dis. 40:1987;593-600.
15. Torrance G.W. Measurement of health state utilities for economic appraisal. J Health Economics. 5:1986;1-30.
16. Torrance G.W., Feeny D. Utilities and quality-adjusted life years. Int J Tech Assoc Health Care. 5:1989;559-575.
17. Sintonen H. An approach to measuring and valuing health states. Soc Sci Med. 15:1981;55-65.
18. Mohide E.A., Torrance G.W., Streiner D.L., Pringle D.M., Gilbert R. Measuring the well being of family caregivers using the time trade-off technique. J Clin Epi. 41:1988;475-482.
19. Bennett K.J., Torrance G.W., Moran L.A., Smith F., Goldsmith C.H. Health State Utilities in Knee Replacement Surgery. the development and validation of McKnee Journal of Rheumatology. 24:1997;1796-1805.
20. Krahn M.D., Mahoney J.E., Eckman M.H., Trachtenberg J., Pauker S.G., Detsky A.S. Screening for prostate cancer. a decision analytic view JAMA. 272:1994;781-786.
21. Cantor S.B., Spann S.J., Volk R.J., Cardenas M.P., Warren M.M. Prostate cancer screening. a decision analysis J Fam Pract. 41:1995;33-41.
22. Fleming C., Wasson J.H., Albertsen P.C., Barry M.J., Wennberg J. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 269:1993;2650-2659.
23. Essink-Bot M.L., Stouthard M.E., Bonsel G.J. Generalizability of valuations on health states collected with the EuroQol questionnaire. Health Economics. 2:1993;237-246.
24. Kaplan R.M., Anderson J.P., Wu A.W., Mathews C., Kozin F., Orenstein D. The Quality of Well-Being scale. Applications in AIDS, cystic fibrosis, and arthritis. Med Care. 27:1989;S27-s43.
25. Fossa SD, Aaronson N, deVoogt HJ, daSilva FC. Assessment of quality of life and subjective response criteria in patients with prostatic cancer. In: EORTC Genitourinary Group Monograph 7: Prostate Cancer and Testicular Cancer. New York: Wiley-Liss, Inc., 1990. pp. 199-202.
26. da Silva F.C. Quality of life in prostatic cancer patients. Cancer. 72:1993;3803-3806.
27. Fossa S.D., Aaronson N.K., Newling D.et al. Quality of life and treatment of hormone resistant metastatic prostatic cancer. Eur J Cancer. 26:1990;1133-1136.
28. Parmar H., Phillips R.H., Lightman S.L., Edwards L. How would you like to have an orchidectomy for advanced prostatic cancer. Am J Clin Oncol. 11(suppl.2):1988;160-168.
29. Villavicencio H. Quality of life of patients with advanced and metastatic prostatic carcinoma. European Urology. 24(suppl. 2):1993;118-121.
30. Cassileth B.R., Soloway M.S., Vogelzang N.J.et al. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res. 1:1992;323-330.
31. Herr H., Kornblith A.B., Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer. 71:1993;1143-1150.
32. Pedersen K.V., Carlsson P., Rahmquist M., Varenhorst E. Quality of life after radical retropubic prostatectomy for carcinoma of the prostate. Eur Urol. 35:1993;7-11.
33. Litwin M.S., Fink A., Hays R.D.et al. Quality of life in men with prostate cancer. a pilot study J Urol. 149:1993;494A.
34. Kornblith A.B., Herr H.W., Ofman U.S., Scher H.I., Holland J.C. Quality of life of patients with prostate cancer and their spouses. The value of a data base in clinical care. Cancer. 73:1994;2791-2802.
35. Herr H.W. Quality of life of incontinent men after radical prostatectomy. J Urol. 151:1994;652-654.
36. Payne R. Pain management in the patient with prostate cancer. Cancer. 71:1993;1131-1137.
37. Litwin M.S., Hays R.D., Fink A.et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
38. Braslis K.G., Santa-Cruz C., Brickman A.L., Soloway M.S. Quality of life 12 months after radical prostatectomy. Br J Urol. 75:1995;48-53.
39. Fowler F.J., Barry M.J., Lu-Yao G., Wannson J. Effect of radical prostatectomy for prostate cancer on patient quality of life. results from a Medicare survey Urology. 45:1995;1007-1013.
40. McHorney C.A., Ware J.E., Rogers W., Raczek A.E., Lu J.F. The validity and relative precision of MOS Short- and Long-Form health status scales and Dartmouth COOP charts. Med Care. 30:1992;MS253-MS265.
41. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-item short-form health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care. 31:1993;247-263.
42. McHorney C.A., Ware J.E., Rachel Lu J.F.R., Donald Sherbourne C. The MOS 36-item short-form health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care. 32:1994;40-66.
43. Hunt S.M., McKenna S.P., McEwen J., Williams J., Papp E. The Nottingham Health Profile. subjective health status and medical consultations Soc Sci Med. 15A:1981;221-228.
44. Bergner M., Bobbitt R.A., Carter W.B., Gilson B.S. The Sickness Impact Profile. development and final revision of a health status measure Med Care. 19:1981;787-805.
45. Ganz P.A., Schag C.A.C., Lee J.J., Sim M.S. The cares. a genetic measure of health-related quality of life for patients with cancer Qual Life Res. 1:1992;19-29.
46. Schipper H., Clinch J., McMurray A., Levitt M. Measuring the quality of life of cancer patients. the Functional Living Index-Cancer J Clin Oncol. 2:1984;472-483.
47. Aaronson N.K., Ahmedzai S., Bergman G.et al. The European Organization for Research and Treatment of Cancer QLQ-C30. a quality of life instrument for use in international clinical trials in oncology JNCI. 85:1993;365-376.
48. Gelber R.D., Goldhirsch A., Cole B.F. Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. Controlled Clin Trials. 14:1993;485-499.
49. Selby P.J., Chapman J.A.W., Etazadi-Amoli J., Dalley D., Boyd N.F. The development of a method for assessing the quality of life of cancer patients. Br J Cancer. 50:1984;13-22.
50. Cella D.F., Tulsky D.S., Gray G.et al. The Functional Assessment of Cancer Therapy scale. development and validation of the general measure J Clin Oncol. 11:1993;570-579.
51. Cella D.F., Jacobsen P.B., Orav E.J., Holland J.C., Silberfarb P.M., Rafla S. A brief POMS measure of distress for cancer patients. J Chron Dis. 40:1987;939-942.
52. Stockler M., Osoba D., Goodwin P., Corey P., Tannock I.F. Responsiveness to change in health related quality of life. a comparison of the prostate cancer specific quality of life instrument (PROSQOLI) with a modular EORTC instrument in a positive randomized trial J Clin Epidemiol. 51:1998;137-145.
53. Furlong W.H., Torrance G.W., Feeny D., Boyle M.H. McMaster Health Utilities Index of health-related quality of life. Qual Life Res. 3:1994;76.
54. Van Agt H.M.E., Essink-Bot M.L., Krabbe P.F.M., Bonsel G.J. Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med. 39:1994;1537-1544.
55. Morrison D.F. Multivariate Statistical Methods. 1990;McGraw-Hill, New York.
56. Efron B., Tibshirani R.J. An Introduction to the Bootstrap. 1993;Chapman and Hall, New York.
57. Glass G.V., Peckham P.D., Sanders J.R. Consequences of failure to meet assumptions underlying the fixed effects analyses of variance and covariance. Collier R.O. Jr., Hummel T.J. Experimental Design and Interpretation. 1977;507-565 McCutchan, Berkeley.
58. Miller G.A. The magical number seven plus or minus two. some limits on our capacity to process information Psychol Rev. 63:1956;81-97.
59. Froberg D.G., Kane R.L. Methodology for measuring health-state preferences-II. scaling methods J Clin Epidemiol. 42:1989;459-471.
60. Torrance GW, Zhang Y, Feeny D, Furlong W, Barr W. Multi-attribute preference functions for a comprehensive Health Status Classification System, McMaster University Technical Document (Centre for Health Economics and Policy Analysis Working Paper Series, 92-18), 1992.
61. Cella D.F., Tulsky D.S. Quality of life in cancer. definition, purpose, and method of measurement Cancer Invest. 11:1993;327-336.
62. Aaronson N.K., Ahmedzai S., Bergman B.et al. The European Organization for Research and Treatment of Cancer QLQ-C30. a quality-of-life instrument for use in international clinical trials in oncology JNCI. 85:1993;365-376.
63. Ware J.E., Donald Sherbourne C. The MOS 36-item short-form health survey (SF-36) 1. Conceptual framework and item selection. Med Care. 30:1992;473-481.